A single use qualitative immunoassay used to detect the circulating antibodies to Human Immunodeficiency Virus Type 1 (HIV-1), Type 2 (HIV-2) and distinguish between recent and long-term infection in HIV-1/2.

This is a point of care (POC) test intended for use with blood or serum/ plasma specimens. The Maxim Swift™ HIV RIA uses US CDC developed materials and is designed for surveillance purposes such as estimating HIV-1 incidence in a population, monitoring and evaluating HIV intervention programs, and recognizing those high-incidence populations so that prevention research, vaccine trials, and resources are most appropriately utilized. 

​

This product is for research use only and is not intended for use in diagnostic procedures.